Aggressive Fibromatoses
📧 Sign up to get email alerts when something new happens for Aggressive Fibromatoses.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis [Phase 2]
Phase 2 trial evaluating doxorubicin-eluting intra-arterial embolization for aggressive desmoid fibromatosis has completed.